Cullinan Therapeutics, Inc.
corporate_fare Company Profile
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for CGEM at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- FDA Accepts Zipalertinib NDA, Sets Feb 2027 PDUFA Date; Cullinan Therapeutics Details Q1 & Pipeline
- Cullinan Therapeutics Establishes New $200M At-The-Market Equity Offering Program
- Cullinan Therapeutics Files 10-K, Details Zipalertinib NDA Submission, Fast Track, and Cash Runway into 2029
- Cullinan Therapeutics Reports FY25 Results, Strong Cash Runway, and Key Pipeline Milestones
- Cullinan Therapeutics Reports Strong Cash Position and Key Pipeline Milestones, Including Fast Track and NDA Progress
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$219.88M
Op. Cash Flow
-$175.75M
Free Cash Flow
-$175.8M
Operating Income
-$241.65M
Cash & Equivalents
$88.33M
Debt / Equity
0.00×
Shares Outstanding
60.24M sh
Source: 10-K · filed 2026-03-10 · accession 0001193125-26-099362
show_chartPrice Chart
Loading chart...
feed CGEM - Filings & News (Page 2)
CGEM
May 07, 2026, 7:00 AM EDT
Price at Filing:
$15.15
Real-time Price:
$8.96
Change:
-$6.19 (-41%)
Market Cap:
$577.147M
CGEM
Apr 28, 2026, 7:52 AM EDT
Price at Filing:
$13.30
Real-time Price:
$8.96
Change:
-$4.34 (-33%)
Market Cap:
$577.147M
CGEM
Mar 10, 2026, 7:26 AM EDT
Price at Filing:
$15.44
Real-time Price:
$8.96
Change:
-$6.48 (-42%)
Market Cap:
$577.147M
CGEM
Mar 10, 2026, 7:23 AM EDT
Price at Filing:
$15.44
Real-time Price:
$8.96
Change:
-$6.48 (-42%)
Market Cap:
$577.147M
CGEM
Jan 08, 2026, 7:15 AM EST
Price at Filing:
$11.05
Real-time Price:
$8.96
Change:
-$2.09 (-19%)
Market Cap:
$577.147M